D. Sisci

S. Andò, S. Aquila, M. Lanzino, 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Thyroid hormone modulates androgen and oestrogen receptor content in the Sertoli cells of peripubertal rats.

S. Andò, M. Lanzino, D. Sisci, 1996, The Journal of endocrinology.

Influence of thyroid hormone on androgen metabolism in peripuberal rat Sertoli cells.

S. Andò, M. Lanzino, D. Sisci, 1994, The Journal of endocrinology.

Changes of intratesticular sex steroid concentrations during the annual spermatogenic cycle of male lizards Podarcis sicula

G. Bolelli, S. Andò, S. Aquila, 1992 .

Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor

S. Andò, M. Pellegrino, P. Rizza, 2016, Oncotarget.

Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines

I. Barone, S. Catalano, S. Andò, 2014, Breast Cancer Research.

G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.

S. Fuqua, S. Andò, S. Aquila, 2009, Molecular endocrinology.

Expression of nuclear insulin receptor substrate 1 in breast cancer

S. Andò, S. Cascio, E. Surmacz, 2006, Journal of Clinical Pathology.

Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer

Giuseppina Augimeri, C. Giordano, L. Gelsomino, 2020, Cells.

LPL, FNDC5 and PPARγ gene polymorphisms related to body composition parameters and lipid metabolic profile in adolescents from Southern Italy

C. Giordano, I. Barone, S. Catalano, 2022, Journal of translational medicine.

AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells

S. Andò, M. Lanzino, C. Morelli, 2019, BMC Cancer.

Progesterone Receptor B signaling Reduces Breast Cancer Cell Aggressiveness: Role of Cyclin-D1/Cdk4 Mediating Paxillin Phosphorylation

S. Andò, S. Aquila, M. Lanzino, 2019, Cancers.

Leptin increases HER2 protein levels through a STAT3‐mediated up‐regulation of Hsp90 in breast cancer cells

C. Giordano, I. Barone, S. Catalano, 2013, Molecular oncology.

Endemic goiter in Calabria: Etiopathogenesis and thyroid function

S. Andò, A. Mariano, D. Sisci, 1994, Journal of endocrinological investigation.

Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer

F. Sotgia, M. Fiorillo, M. Lisanti, 2017, Oncotarget.

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

S. Andò, S. Aquila, D. Sisci, 2008, Endocrinology.

Inhibition of leydig tumor growth by farnesoid X receptor activation: The in vitro and in vivo basis for a novel therapeutic strategy

C. Giordano, I. Barone, S. Catalano, 2013, International journal of cancer.

Nutrition Education Program and Physical Activity Improve the Adherence to the Mediterranean Diet: Impact on Inflammatory Biomarker Levels in Healthy Adolescents From the DIMENU Longitudinal Study

C. Giordano, I. Barone, S. Catalano, 2021, Frontiers in Nutrition.

FoxO 3 a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer

C. Giordano, D. Bonofiglio, F. Sotgia, 2019 .

Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells

S. Andò, D. Sisci, E. Surmacz, 1999, International journal of cancer.

Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.

S. Andò, C. Morelli, D. Sisci, 2016, Mini reviews in medicinal chemistry.

Self-Perceived Physical Activity and Adherence to the Mediterranean Diet in Healthy Adolescents during COVID-19: Findings from the DIMENU Pilot Study

C. Giordano, D. Bonofiglio, D. Sisci, 2021, Healthcare.

Potential Antioxidant and Anti-Inflammatory Properties of Serum from Healthy Adolescents with Optimal Mediterranean Diet Adherence: Findings from DIMENU Cross-Sectional Study

Giuseppina Augimeri, C. Giordano, I. Barone, 2021, Antioxidants.

The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment

Giuseppina Augimeri, C. Giordano, I. Barone, 2023, Cancers.

AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells

S. Andò, M. Lanzino, C. Morelli, 2019, BMC cancer.

Preparation and cell inclusion of fluorescent folic acid-functionalized mesoporous silica microspheres potentially useful for drug targeting

J. Nagy, S. Andò, C. Morelli, 2007 .

Serum from Adolescents with High Polyphenol Intake Exhibits Improved Lipid Profile and Prevents Lipid Accumulation in HepG2 Human Liver Cells

Giuseppina Augimeri, C. Giordano, I. Barone, 2023, Oxidative medicine and cellular longevity.

The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.

S. Andò, A. Russo, S. Cascio, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Controlled Release of 5-FU from Chi–DHA Nanoparticles Synthetized with Ionic Gelation Technique: Evaluation of Release Profile Kinetics and Cytotoxicity Effect

A. Nigro, C. Morelli, D. Sisci, 2020, Journal of functional biomaterials.

ENGINEERED MESOPOROUS SILICA-BASED NANOPARTICLES AS SMART CHEMOTHERAPY FOR BORTEZOMIB ADMINISTRATION

G. Cavaletti, A. Nigro, I. Perrotta, 2022, Materials Chemistry Frontiers.

Androgens Modulate Bcl-2 Agonist of Cell Death (BAD) Expression and Function in Breast Cancer Cells

S. Catalano, S. Andò, M. Lanzino, 2023, International journal of molecular sciences.

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

S. Andò, S. Aquila, D. Sisci, 2008, Endocrinology.

Bergapten induces metabolic reprogramming in breast cancer cells.

E. Cione, S. Aquila, D. Sisci, 2016, Oncology reports.